ask="49.00"
ask_size="1100"
average_daily_volume="386147"
bid="N/A"
bid_size="N/A"
book_value="14.89"
change="+0.60"
change_from_200_day_moving_average="-4.07"
change_from_50_day_moving_average="-1.57"
change_from_52_week_high="-14.95"
change_From_52_week_low="17.99"
change_in_percent="+1.32%"
close="46.03"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="8.95"
ebitda="267.62M"
eps_estimate_current_year="-2.27"
eps_estimate_next_quarter="-0.74"
eps_estimate_next_year="-3.15"
ex_dividend_date="N/A"
float_shares="24015000"
high="46.90"
high_52_weeks="60.98"
last_trade_date="2/9/2017"
last_trade_price="46.03"
last_trade_size="17501"
last_trade_time="4:00pm"
low="44.70"
low_52_weeks="28.04"
market_capitalization="1.25B"
moving_average_200_day="50.10"
moving_average_50_day="47.60"
name="Five Prime Therapeutics
Inc."
notes="N/A"
one_year_target_price="60.17"
open="45.43"
pe_ratio="5.14"
peg_ratio="0.34"
percent_change_from_200_day_moving_average="-8.11%"
percent_change_from_50_day_moving_average="-3.29%"
percent_change_from_52_week_high="-24.52%"
percent_change_from_52_week_low="+64.16%"
previous_close="45.43"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.05"
price_per_sales="3.20"
revenue="385.77M"
shares_outstanding="27138000"
short_ratio="6.16"
stock_exchange="NMS"
symbol="FPRX"
volume="380979"
weeks_range_52="28.04 - 60.98"
